Tolaney SM - Search Results

1

The Effects of Diabetes and Glycemic Control on Cancer Outcomes in Individuals With Metastatic Breast Cancer.

Cheung YM, Hughes M, Harrod J, Files J, Kirkner G, Buckley L, Lin NU, Tolaney SM, McDonnell ME, Min L. Cheung YM, et al. Among authors: tolaney sm. J Clin Endocrinol Metab. 2022 Aug 18;107(9):2511-2521. doi: 10.1210/clinem/dgac375. J Clin Endocrinol Metab. 2022. PMID: 35766387 Free PMC article.

2

Sarcoidosis mimicking metastatic breast cancer.

Tolaney SM, Colson YL, Gill RR, Schulte S, Duggan MM, Shulman LN, Winer EP. Tolaney SM, et al. Clin Breast Cancer. 2007 Oct;7(10):804-10. doi: 10.3816/CBC.2007.n.044. Clin Breast Cancer. 2007. PMID: 18021484

3

The evolving understanding of small HER2-positive breast cancers: matching management to outcomes.

Waks AG, Tolaney SM. Waks AG, et al. Among authors: tolaney sm. Future Oncol. 2015;11(24):3261-71. doi: 10.2217/fon.15.240. Epub 2015 Nov 13. Future Oncol. 2015. PMID: 26634944 Review.

4

Randomized trial of a physical activity intervention in women with metastatic breast cancer.

Ligibel JA, Giobbie-Hurder A, Shockro L, Campbell N, Partridge AH, Tolaney SM, Lin NU, Winer EP. Ligibel JA, et al. Among authors: tolaney sm. Cancer. 2016 Apr 15;122(8):1169-77. doi: 10.1002/cncr.29899. Epub 2016 Feb 12. Cancer. 2016. PMID: 26872302 Free article. Clinical Trial.

5

Cost-effectiveness of palbociclib in hormone receptor-positive advanced breast cancer.

Mamiya H, Tahara RK, Tolaney SM, Choudhry NK, Najafzadeh M. Mamiya H, et al. Among authors: tolaney sm. Ann Oncol. 2017 Aug 1;28(8):1825-1831. doi: 10.1093/annonc/mdx201. Ann Oncol. 2017. PMID: 28472324 Free article.

6

MONARCH 1, A Phase II Study of Abemaciclib, a CDK4 and CDK6 Inhibitor, as a Single Agent, in Patients with Refractory HR⁺/HER2^- Metastatic Breast Cancer.

Dickler MN, Tolaney SM, Rugo HS, Cortés J, Diéras V, Patt D, Wildiers H, Hudis CA, O'Shaughnessy J, Zamora E, Yardley DA, Frenzel M, Koustenis A, Baselga J. Dickler MN, et al. Among authors: tolaney sm. Clin Cancer Res. 2017 Sep 1;23(17):5218-5224. doi: 10.1158/1078-0432.CCR-17-0754. Epub 2017 May 22. Clin Cancer Res. 2017. PMID: 28533223 Free PMC article. Clinical Trial.

7

Optimal Management of Early and Advanced HER2 Breast Cancer.

Hurvitz SA, Gelmon KA, Tolaney SM. Hurvitz SA, et al. Among authors: tolaney sm. Am Soc Clin Oncol Educ Book. 2017;37:76-92. doi: 10.1200/EDBK_175630. Am Soc Clin Oncol Educ Book. 2017. PMID: 28561711 Free article. Review.

8

Incidence of Endocrine Dysfunction Following the Use of Different Immune Checkpoint Inhibitor Regimens: A Systematic Review and Meta-analysis.

Barroso-Sousa R, Barry WT, Garrido-Castro AC, Hodi FS, Min L, Krop IE, Tolaney SM. Barroso-Sousa R, et al. Among authors: tolaney sm. JAMA Oncol. 2018 Feb 1;4(2):173-182. doi: 10.1001/jamaoncol.2017.3064. JAMA Oncol. 2018. PMID: 28973656 Free PMC article.

9

Occurrence and significance of morphologic changes in patients with metastatic triple negative breast cancer treated with Cabozantinib.

Shinagare AB, Somarouthu B, Guo H, Tolaney SM, Ramaiya NH. Shinagare AB, et al. Among authors: tolaney sm. Clin Imaging. 2018 Mar-Apr;48:44-47. doi: 10.1016/j.clinimag.2017.09.014. Epub 2017 Sep 28. Clin Imaging. 2018. PMID: 29028513 Clinical Trial.

10

Characterization of Thyroid Disorders in Patients Receiving Immune Checkpoint Inhibition Therapy.

Lee H, Hodi FS, Giobbie-Hurder A, Ott PA, Buchbinder EI, Haq R, Tolaney S, Barroso-Sousa R, Zhang K, Donahue H, Davis M, Gargano ME, Kelley KM, Carroll RS, Kaiser UB, Min L. Lee H, et al. Cancer Immunol Res. 2017 Dec;5(12):1133-1140. doi: 10.1158/2326-6066.CIR-17-0208. Epub 2017 Oct 27. Cancer Immunol Res. 2017. PMID: 29079654 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

311 results

Search Page